ERBB2 and ductal breast carcinoma in situ: However, much less has been reported on the comparison of the status of ER, PR, HER2, and Ki-67 between paired CNB sample and surgical specimen in patients with a final diagnosis of both DCIS and IDC separately5,7–12.